Marker Therapeutics Inc (MRKR)

[guydiamond]

It means your (the patient's) natural immune system is joining in on the fight. They are seeing NEW t-cells that target antigens on the tumor that WERE NOT part of their therapy.

But, I think correlative means they aren't able to strictly attribute this effect to their therapy. Somebody correct me though; I'm not an expert on terminology and implications of biotech trial analyses.